Last Updated: November 8, 2026

Details for Patent: 7,235,627

Name: Drug Patent Intelligence for US Patent 7235627
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Summary for Patent: 7,235,627

Title:	Derivatives of GLP-1 analogs
Abstract:	The present invention relates to a pharmaceutical composition comprising a GLP-1 derivative having a lipophilic substituent; and a surfactant.
Inventor(s):	Liselotte Bjerre Knudson, Per Olaf Huusfeldt, Per Franklin Nielsen
Assignee:	Novo Nordisk AS
Application Number:	US10/285,079
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,235,627
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 7,235,627

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,235,627

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Denmark	0931/96	Aug 30, 1996
Denmark	1259/96	Nov 08, 1996
Denmark	1470/96	Dec 20, 1996

International Family Members for US Patent 7,235,627

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0944648	⤷ Start Trial	CA 2009 00041	Denmark	⤷ Start Trial
European Patent Office	0944648	⤷ Start Trial	SPC034/2009	Ireland	⤷ Start Trial
European Patent Office	0944648	⤷ Start Trial	SPC/GB09/058	United Kingdom	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.